Quest Diagnostics Inc's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Quest Diagnostics Inc's ROA in the third quarter of 2026?
Quest Diagnostics Inc achieved a return on average assets (ROA) of 6.9 % in its third quarter of 2026, which is below Quest Diagnostics Inc's average return on assets, which stands at 8.11%.

Despite the company's net income deteriorating, Quest Diagnostics Inc was able to improve its ROA compared to the second quarter of 2026.

However, within the Healthcare sector 127 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 945, from total ROA ranking in the second quarter of 2026 at 1107.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	6.91 %	6.66 %	6.39 %	6.04 %	4.94 %
Y / Y Net Income Change	20.46 %	12.84 %	12.34 %	8.47 %	9.28 %
Net Income (TTM) in million	1,166	1,113	1,075	1,046	1,026
Return On Assets (TTM)	6.9 %	6.7 %	6.57 %	6.5 %	6.47 %
DGX's Total Ranking	# 945	# 1107	# 969	# 988	# 1020
Total Assets (TTM) in million	17,317	17,033	16,807	16,439	16,197
Seq. Total Assets Change	1.67 %	1.34 %	2.24 %	1.49 %	1.43 %
Seq. Net Income Change	-6.59 %	26.52 %	3.13 %	-1.16 %	-12.5 %

DGX's 5 Years Annual ROA >> Back to DGX Management Effectiveness >> Compare DGX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 4
Sector	# 128
Overall	# 898

Return On Assets Statistics
High	Average	Low
17.03 %	8.11 %	4.28 %
(Jun 30 2021)		(Dec. 31, 2007)

Financial Statements
Quest Diagnostics Inc's Assets	$ 17,317 million	DGX's Balance sheet
Quest Diagnostics Inc's Income	$ 312 million	Quarterly DGX's Income Statement
DGX's Income by Division		See DGX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	5.54 %	15.51 %	9.53 %	-5.86 %	-3.04 %
Total Assets in million	16,361	15,502	13,420	12,252	13,014
Y / Y Net Income Change	13.57 %	1.43 %	-10.54 %	-51.2 %	38.76 %
Net Income in million	1,046	921	908	1,015	2,080
Annual Return On Assets	6.39 %	5.94 %	6.77 %	8.28 %	15.98 %

DGX's 5 Years Annual ROA >> Back to DGX Management Effectiveness >> Compare DGX ROA to its Competitors

Comment on DGX's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 6.39 % compared to prior year, due to annual net income growth of 13.57 % to $1,046.00 million, while value of Quest Diagnostics Inc's overall assets grew just by 5.54 % to $16,361.00 million, compared to $16,361.00 a year before.

More Return On Assets Ratios
DGX's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
DGX's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for DGX's Competitors
Subscribers only: Roa for Quest Diagnostics Inc's Suppliers
Subscribers only: Return On Assets for DGX's Customers

You may also want to know
DGX's Roi	DGX's Inventory Turnover Ratio	DGX's Growth Rates	DGX's Dividend Comparisons
	DGX's Profitability Ratios	DGX's Asset Turnover Ratio	DGX's Dividend Growth
DGX's Roe	DGX's Valuation Ratios	DGX's Financial Strength Ratios	DGX's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %
Inspire Medical Systems inc	10.89 %
Transmedics Group Inc	10.67 %
Bristol myers Squibb Company	10.47 %
Lemaitre Vascular Inc	10.28 %
Bio rad Laboratories Inc	9.88 %
3m Company	9.60 %
Bioventus Inc	9.47 %

Date modified: 2026-10-24T15:37:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.